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Suppressor of Cytokine Signaling-1 Is
a Critical Regulator of Interleukin-7-Dependent
CD8 T Cell Differentiation
have important functions later in thymocyte develop-
ment and in mature T cells.
Overexpression of suppressor of cytokine signaling-1
(SOCS-1) inhibits JAK-STAT signaling by many cyto-
kines, including IL-2, IL-6, IL-7, and interferons (Alexan-
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The SOCS-1/ disease is thought to be due to hyper-
sensitivity of tissues to interferon- (IFN) (Alexander etTo determine the tissue-specific functions of SOCS-1,
al., 1999). Neonatal mice injected with IFN developmice were generated in which the SOCS-1 gene could
fatty degeneration of the liver and a disease similar tobe deleted in individual tissues. A reporter gene of
SOCS-1/ mice (Gresser et al., 1981). Furthermore,SOCS-1 promoter activity was also inserted. Using the
IFN-induced STAT1 activation is prolonged in SOCS-reporter, high SOCS-1 expression was found at the
1/ hepatocytes (Brysha et al., 2001), while IFN defi-CD4CD8 stage in thymocyte development. To inves-
ciency prevents the neonatal disease in SOCS-1/ micetigate the function of this expression, the SOCS-1 gene
(Alexander et al., 1999).was specifically deleted throughout the thymocyte/T/
SOCS-1 deficiency causes aberrant activation ofNKT cell compartment. Unlike SOCS-1/ mice, these
T cells and NKT cells, which are proposed as the keymice did not develop lethal multiorgan inflammation
cellular mediators of the SOCS-1/ disease (Marine etbut developed multiple lymphoid abnormalities, in-
al., 1999; Naka et al., 2001). Removal of lymphocytescluding enhanced differentiation of thymocytes to-
by Rag2 deficiency prevents the neonatal lethality inward CD8 T cells and very high percentages of peri-
SOCS-1/ mice (Marine et al., 1999). SOCS-1/ micepheral CD8 T cells with a memory phenotype
have increased circulating levels of IFN, which also(CD44hiCD25loCD69lo). These phenotypes were found
suggests the presence of activated T cells (Marine etto correlate with hypersensitivity to the -common
al., 1999). In addition, NKT cell depletion reduces thefamily of cytokines.
severity of the liver damage in SOCS-1/ mice, whereas
NKT cell stimulation accelerates the disease, suggesting
Introduction that hepatic NKT cells mediate the liver disease (Naka
et al., 2001).
Members of the -common (c) family of cytokines, in- The neonatal lethality of the SOCS-1/ disease has
cluding interleukin (IL)-2, 7, and 15, act on target cells complicated the ability to investigate the functions of
through receptors containing the c chain. These cyto- SOCS-1 in adult tissues. In the present study, the Cre/
kines signal via the Janus kinase (JAK) signal transducer LoxP system was employed to generated mice in which
and activator of transcription (STAT) pathway, activating the SOCS-1 gene could be conditionally deleted in spe-
JAK1, JAK3, STAT5a, and STAT5b (Lin and Leonard, cific tissues. By deleting SOCS-1 specifically in the thy-
1997). Studies in humans and mice have demonstrated mocyte/T cell compartment, we show that SOCS-1 has
the critical role c cytokines play in T cell development. an important function in regulating IL-7-dependent
Mutations in any of the genes encoding JAK3, c, or CD8 T cell differentiation.
IL-7 receptor  chain (IL-7R) causes severe combined
immunodeficiency and a block in early thymocyte devel-
Resultsopment (Leonard, 2001). Targeted gene deletion recapit-
ulates similar phenotypes in mice. IL-7 also appears to
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Figure 1. Functional Floxing of the SOCS-1 Gene in Mice and the Analysis of SOCS-1 Expression during T Cell Development
(A) Shown are the structure of the murine SOCS-1 locus and the targeting strategy used to flox the SOCS-1 gene.
(B) The SOCS-1lox allele functionally replaces the endogenous SOCS-1 gene in mice. SOCS-1lox/lox,lox/ mice are healthy. The SOCS-1/ survival
rate is recapitulated in SOCS-1lox/ CMV-Cre mice but not SOCS-1lox/ Lck-Cre mice.
(C) CMV-Cre deletes the SOCS-1lox allele and mRNA. (i) SOCS-1 genotyping was performed by Southern analysis of genomic DNA hybridized
with probe A (indicated in [A]). (ii) CMV-Cre genotyping was performed by PCR. (iii) SOCS-1lox deletion confirmed by Southern analysis of
genomic DNA hybridized with probe B. Length flanked by the LoxP sites  1.5 kb. (iv) Loss of SOCS-1 expression from the recombined
SOCS-1lox allele confirmed by Northern analysis of thymic RNA.
(D) Recombination of the SOCS-1lox gene brings the hCD4 reporter under the control of the SOCS-1 promoter.
(E) To examine whether the hCD4 reporter was functional, SOCS-1lox/ mice were crossed with CMV-Cre mice, which activates the reporter
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1lox/lox homozygous or SOCS-1lox/ heterozygous mice Transgenic Expression of Cre under the Lck
Promoter Specifically Deletes SOCS-1loxwere healthy and did not develop the SOCS-1/ disease
(Figure 1B and data not shown). in T Cells and NKT Cells
SOCS-1 is expressed at particularly high levels in DPTo confirm that the LoxP sites were functional, SOCS-
1lox/ mice were bred with transgenic mice expressing thymocytes. To address the function of this expression,
SOCS-1 was deleted from thymocytes and T cells butCre under the CMV promoter (CMV-Cre). Because CMV-
Cre is expressed early in embryogenesis (Schwenk et not other tissues, using Cre expressed under the Lck-
promoter (Lck-Cre). SOCS-1lox recombination in SOCS-al., 1995), any recombination event is transmitted on to
all cells in the mouse. The SOCS-1lox gene and mRNA 1lox/ Lck-Cre mice was analyzed by tracking hCD4
expression. Individual cell populations from multiple tis-were absent from mice that were also CMV-Cre trans-
genic (Figure 1C). Moreover, SOCS-1lox/ CMV-Cre sues were analyzed. hCD4 was detected on CD4 and
CD8 T cells, and CD3NK1.1 NKT cells but not in NK(SOCS-1CMV-lox) mice succumb to the same disease as
SOCS-1/ mice (Figure 1B). cells, B cells, monocytes, or granulocytes (Figure 2A
and data not shown; only splenocyte data is shown).
In addition, IFN (which upregulates SOCS-1 promoterSOCS-1 Is Differentially Expressed
activity) only upregulated hCD4 expression on T cellsduring T Cell Development
and NKT cells. This contrasts the positive controlTo track the deletion of the SOCS-1lox allele in individual
SOCS-1lox/ CMV-Cre mice, in which there was hCD4cells, a reporter gene was inserted immediately 3 of
expression on all populations examined.the SOCS-1lox gene (Figure 1A). Human CD4 (hCD4) con-
SOCS-1lox deletion in both T and NKT cells suggeststaining a F43I mutation and intracellular truncation,
that Lck-Cre might function at a common developmentalwhich abrogate its function (Sakihama et al., 2000), was
stage. Approximately 10% of DNI thymocytes ex-employed as the reporter. In the event that the SOCS-1lox
pressed hCD4, which increased to almost 100% in ISPgene is deleted by Cre, the hCD4 reporter is expressed in
and DP thymocytes (Figure 2B), implying that SOCS-1loxplace of SOCS-1 (Figure 1D). hCD4 therefore acts both
deletion by Lck-Cre occurs entirely during thymocyteas a marker of SOCS-1lox deletion and a reporter of
development. The transmission of SOCS-1lox deletion toSOCS-1 promoter activity.
both T and NKT cells is consistent with previous evi-SOCS-1lox/ CMV-Cre mice, in which all cells carry the
dence suggesting that NKT cells are thymocyte derivedrecombination event, were analyzed for hCD4 expres-
(Gapin et al., 2001; Pellicci et al., 2002).sion. The cortex of the thymus stained strongly for hCD4,
while the thymic medulla and the spleen only stained
weakly (Figure 1E). The comparatively high level of hCD4 Mice with Specific Deletion of SOCS-1 within
the Thymocyte/T Cell Compartment Displayexpression in the thymus was also evident by flow cy-
tometry (Figure 1F). The thymus has previously been Abnormal T Cell Population Sizes
Mice with thymocyte/T cell-specific SOCS-1 deficiencyshown to express high levels of SOCS-1 at the mRNA
level (Starr et al., 1997). Nonlymphoid organs did not (SOCS-1Lck-lox) were generated by intercrossing SOCS-
1/, SOCS-1lox/, and Lck-Cre mice together in order tostain for the reporter (data not shown). hCD4 staining
was not detected in the tissues of SOCS-1lox/ nontrans- obtain progeny carrying one SOCS-1 null allele, one
SOCS-1lox allele, and the Lck-Cre transgene (i.e.,genic mice, demonstrating that the reporter is only ex-
pressed if the SOCS-1lox gene is deleted. SOCS-1lox/ Lck-Cre). With only one SOCS-1lox allele re-
quiring recombination, any cell that switched on theSOCS-1 expression at each stage of thymocyte devel-
opment was then quantified using the hCD4 reporter hCD4 reporter could be considered deficient in both
copies of the SOCS-1 gene. This breeding strategy also(Figure 1G). All CD4CD8 double-negative thymocytes
(DNI to DNIV) expressed low levels of hCD4. hCD4 ex- generated littermate SOCS-1lox/ nontransgenic genetic
controls. Importantly and corresponding to expressionpression was upregulated to intermediate levels on
CD8CD3 immature single-positive (ISP) thymocytes, of the hCD4 reporter, SOCS-1 protein was absent from
the thymocytes of SOCS-1Lck-lox mice but not SOCS-1lox/-then to high levels on CD4CD8 double-positive (DP)
thymocytes. All mature thymocytes, CD4 single-posi- nontransgenic mice (Figure 2C).
Unlike SOCS-1/ and SOCS-1CMV-lox mice, SOCS-1Lck-loxtive (CD4SP), CD8 single-positive (CD8SP), and
CD3CD4CD8 natural killer T (NKT) cells expressed mice survived past weaning and by 5 months of age still
appeared healthy (Figure 1B). However, multiplelow levels of hCD4. Importantly, hCD4hi expression was
found to correlate with high levels of SOCS-1 protein in lymphoid abnormalities became evident. In mice exam-
ined at 6 weeks of age, cell counts revealed an increaseDP thymocytes (Figure 1H). This confirms a previous
study that reported SOCS-1 protein expression in DP in the cellularity of some lymphoid organs (Figure 3A).
The lymph nodes of SOCS-1Lck-lox mice were enlargedthymocytes (Marine et al., 1999).
in all cells. hCD4 expression was examined by immunohistochemistry (brown stain). Shown are the thymus and spleen. C, thymic cortex; M,
thymic medulla.
(F) hCD4 expression on thymocytes compared with peripheral lymphocytes measured by flow cytometry.
(G) Thymocyte developmental stages were analyzed for hCD4 staining. The results from four experiments (mean SD) are expressed as mean
fluorescence intensity. The dashed line indicates the background fluorescence on SOCS-1lox/ nontransgenic thymocytes.




and contained 2-fold the number of cells compared with
littermate controls. There was a marginal but significant
increase in the cellularity of the SOCS-1Lck-lox thymus.
No difference was found in the spleen. The increased
thymic cellularity is in contrast to SOCS-1/ mice, in
which there is thymic atrophy due to loss of DP thymo-
cytes (Marine et al., 1999; Starr et al., 1998). Thus, the
thymic atrophy in SOCS-1/ mice is likely to be a result
of the disease in these animals.
An analysis of thymic populations in SOCS-1Lck-lox mice
at 6 weeks of age revealed a large increase in the per-
centage and number of CD8SP thymocytes (Figure 3B).
The preferential increase in CD8SP thymocytes resulted
in a marked increase in the ratio of mature
CD8SP:CD4SP thymocytes from 1:4 to 1:1. Although the
percentage of DP thymocytes was marginally reduced,
the absolute of number of DP thymocytes in SOCS-1Lck-lox
mice (1.6  0.1  108 , n  6) was no different from
controls (1.5  0.1  108 , n  6). Similarly, there was
no change in the size of the DN and ISP populations
(data not shown). Mature thymocytes, both CD4SP and
CD8SP, in SOCS-1Lck-lox mice were also found to be larger
in size (Figure 3C). All SOCS-1Lck-lox mice were found to
have enlarged thymic medulla (Figure 3D). This appear-
ance of the medulla may at least be partly a result of
the increases in mature thymocyte numbers and cell
size. However, these alone do not fully account for the
increased medullary region. It is possible that the thymo-
cyte-stroma interaction, which is known to affect stomal
development and architecture (Ritter and Boyd, 1993),
may also be perturbed in these mice.
The increased cellularity of the lymph nodes in
SOCS-1Lck-lox mice was principally due to an increase in
the CD8 T cell population (Figure 3E). Although this
was associated with a large reduction in the percentage
of non-T cells (mostly of B cells), actual numbers were
unchanged. The increased CD8 T cell numbers in the
lymph nodes were also apparent by immunohistochem-
istry, in which enlargement of T cell areas was evident
(Figure 3F).
There were also more CD4 and CD8 T cells in the
blood (Figure 3E). Although the number of T cells in the
spleen was unchanged, there was an increase in the ratio
of CD8:CD4 in SOCS-1Lck-lox mice (Figure 3E). SOCS-
1Lck-lox mice had normal CD3NK1.1 NKT cell numbers
in the blood and spleen (data not shown). None of these
changes in T cell population sizes were due to an immu-
nological response directed against the hCD4 reporterFigure 2. Cre Expressed under the Lck Promoter Deletes SOCS-1lox
because SOCS-1lox/ LckCre mice, which also expressSpecifically in T Cells and NKT Cells
the hCD4 reporter but have one wild-type allele ofRecombination of the SOCS-1lox allele in SOCS-1lox/ Lck-Cre mice
SOCS-1, were indistinguishable from SOCS-1lox/ non-was tracked by analyzing hCD4 expression. SOCS-1lox/ CMV-Cre
mice were used as a positive control. transgenic or SOCS-1/ mice.
(A) IFN-stimulated splenocytes (100 U/ml for 4 hr) were analyzed for
hCD4 expression by flow cytometry and costained with the following T Cell-Specific Deletion of SOCS-1 Results in a
markers to identify individual populations: CD4, CD4 T cells; CD8, Memory Phenotype in CD8 but Not CD4 T Cells
CD8 T cells; CD3NK1.1, NKT cells; CDNK1.1, NK cells; B220, B
Both CD4 and CD8 T cells were reported to be aber-cells. Monocytes/macrophages and granulocytes from SOCS-1lox/
rantly activated in SOCS-1/ mice, expressing high lev-Lck-Cre mice were also examined but were found not to express
hCD4 (data not shown). els of the activation markers CD25, CD44, and CD69
(B) Analysis of Lck-Cre deletion of SOCS-1lox during thymocyte de-
velopment.
(C) SOCS-1lox deletion by Lck-Cre results in the loss of SOCS-1
each time point. The thymocytes from two mice of the same geno-protein in thymocytes. Thymocytes from SOCS-1lox/ Lck-Cre and
littermate genetic controls (SOCS-1lox/ nontransgenic) were ana- type were pooled for the 4 day time points. As a loading control,
2% of the starting lysate was Western blotted for STAT5a/b.lyzed for SOCS-1 expression. 5  107 thymocytes were used for
SOCS-1 Regulates CD8 T Cell Differentiation
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Figure 3. Lymphoid Abnormalities in Mice with Thymocyte/T Cell-Specific SOCS-1 Deficiency
CD8SP thymocyte differentiation is enhanced in SOCS-1lox/ Lck-Cre mice compared with littermate controls (SOCS-1lox/ nontransgenic). For
all parameters shown, six pairs of mice at 40 to 45 days of age were analyzed.
(A) The cellularity of the thymus and lymph nodes is increased in SOCS-1lox/ Lck-Cre mice. The average cell count of each organ per mouseSD
is given. Statistical significance: * p 	 0.05 and ** p 	 0.01 compared with genetic controls.
(B) Total thymocytes or mature thymocytes (gated on TCR
hi) were analyzed for CD4 and CD8 expression by flow cytometry.
(C) Mature thymocytes in SOCS-1lox/ Lck-Cre mice are larger in size, as indicated by higher forward scatter.
(D) The thymic medulla (M) is enlarged in SOCS-1lox/ Lck-Cre mice.
(E) Increased CD8 T cell populations in SOCS-1lox/ Lck-Cre mice are also evident in peripheral lymphoid organs.
(F) Lymph nodes of SOCS-1lox/ Lck-Cre mice have enlarged T cell areas. Frozen sections of mesenteric lymph nodes were stained for either
CD4 or CD8 (brown stain).




(Marine et al., 1999). In SOCS-1Lck-lox mice, most periph- tion was found in SOCS-1-sufficient DP thymocytes.
The expression of the IL-7R and c on all thymocyteeral CD8 T cells in the blood, spleen, and lymph nodes
expressed high levels of CD44 (Figure 3G) but normal populations in SOCS-1Lck-lox mice was the same as in
control mice (Figure 4B and data not shown). Althoughlevels of CD25, CD69, and CD62L (data not shown).
CD44hiCD25loCD69lo expression suggests a memory DP thymocytes expressed low levels of IL-7R, as pre-
viously described (Brugnera et al., 2000), together withphenotype. There was no abnormal expression of any
activation markers on CD4 T cells in SOCS-1Lck-lox mice the high levels of c, this appeared sufficient for IL-7 to
signal in the absence of SOCS-1.(Figure 3G, only CD44 data shown). Almost all CD8SP
thymocytes in SOCS-1Lck-lox mice expressed low levels
of CD44, suggesting that the upregulation of CD44 is SOCS-1-Deficient DP Thymocytes Signaled In Vitro
dependent on a mechanism in the periphery. Therefore, Are Hyperresponsive to IL-7-Induced CD8
the CD44hi phenotype of CD8 T cells in SOCS-1/ mice T Cell Differentiation
is intrinsic to the loss of SOCS-1 within CD8 T cells, To investigate whether IL-7 hypersensitivity may be re-
while induction of CD25 and CD69 on CD8 T cells and sponsible for the enhanced CD8SP differentiation in
the activation of CD4 T cells are dependent on other SOCS-1Lck-lox mice, in vitro thymocyte differentiation sys-
factors. This memory phenotype was not due to the tems were employed. DP thymocytes “signaled” with
hCD4 reporter because it was not evident in SOCS-1lox/ PMA and ionomycin to imitate positive selection in vitro
LckCre mice, which express hCD4 and have one wild- can be induced to differentiate into CD8SP cells in the
type allele of the SOCS-1. Moreover, SOCS-1/IFN/ presence of IL-7 (Brugnera et al., 2000). The effect of
mice, which do not develop the neonatal SOCS-1/ SOCS-1 deficiency on PMA/ionomycin and IL-7-induced
disease, also display a similar memory CD8 T cell phe- differentiation was examined (Figures 4C–4E). Following
notype (Cornish et al., 2003). overnight culture with PMA/ionomycin, all SOCS-1Lck-lox
Although a memory CD8 T cell phenotype was evi- and control DP thymocytes downregulated both CD4
dent in SOCS-1Lck-lox mice, no increase in serum levels and CD8 to become double-negative. The removal of
of IFN was detected. In contrast, SOCS-1CMV-lox mice, PMA/ionomycin and the addition of IL-7 resulted in the
which develop the typical SOCS-1/ disease, had reexpression of CD4 but not CD8 on half of control
greatly elevated levels of IFN in their serum. The serum thymocytes at day 2. CD8SP cells did not appear in
levels of IFN in SOCS-1CMV-lox mice were 200 to 800 control cultures until day 4. CD8SP cells were generated
pg/ml (n  5) compared with 	50 pg/ml in control mice earlier in SOCS-1Lck-lox cultures and in greater percent-
(n 4) (data not shown). In addition, unlike in SOCS-1/ ages at all days compared with control cultures. CD8SP
and SOCS-1CMV-lox mice, inflammatory lesions were not cells were already present in day 2 cultures, with also
found in any SOCS-1Lck-lox mice at 6 to 8 weeks of age. fewer CD4SP cells. Phenotypically, generated CD8SP
Therefore, SOCS-1 deficiency in T and NKT cells alone cells of both genotypes expressed markers typical of
is insufficient to account for the high serum levels of CD8SP thymocytes. CD3 and TCR
 expression were
IFN and the neonatal disease characteristic of SOCS- upregulated, and HSA expression was downregulated
1/ mice. compared with DP thymocytes (data not shown).
Without the addition of IL-7 after PMA/ionomycin
stimulation, CD4SP but not CD8SP cells were generatedSOCS-1-Deficient DP Thymocytes Are Hypersensitive
in both SOCS-1Lck-lox and control cultures (data notto IL-7-Induced STAT5 Phosphorylation
shown). In addition, treatment with IL-7 alone withoutThe positive selection of immature DP thymocytes re-
PMA/ionomycin did not stimulate the differentiation ofquires the productive interaction of the TCR with self-
DP thymocytes (data not shown).MHC to promote survival (Sebzda et al., 1999). The dif-
ferentiation of DP thymocytes into CD4SP or CD8SP
(lineage commitment) requires that the transcription of SOCS-1 Deficiency Increases the Potential of In Vivo
Generated CD4CD8lo (Recently Selected)one coreceptor be terminated (Singer et al., 1999). While
this is thought to be dependent on the specificity of Thymocytes to Differentiate into CD8SP
Cells in Response to IL-7the TCR for either class I or class II MHC, cytokines,
particularly IL-7, may also be important in driving CD8SP Because PMA/ionomycin stimulation is an artificial
means of positively selecting DP thymocytes, welineage commitment (Brugnera et al., 2000; Varas et al.,
1997). Overexpression of SOCS-1 inhibits signaling by wanted to analyze DP thymocytes that were recently
selected in vivo. Recently selected DP thymocytes havecytokines that utilize the JAK-STAT pathway, including
IL-7 (Fujimoto et al., 2000). Suppression of IL-7 signaling been shown to downregulate CD8 expression regard-
less of whether they eventually mature into CD4SP orcould be a function of the SOCS-1hi expression in DP
thymocytes. SOCS-1 deficiency could cause IL-7 hyper- CD8SP (Lundberg et al., 1995; Suzuki et al., 1995). Phe-
notypically, these thymocytes appear as CD4CD8lo andsensitivity during DP thymocytes selection and therefore
the enhanced CD8SP differentiation seen in SOCS-1Lck-lox have the potential to differentiate into either CD4 or
CD8 T cells in vivo and in vitro. By measuring hCD4mice. To examine the effect of SOCS-1 deficiency on
IL-7 sensitivity, purified DP thymocytes were stimulated expression in SOCS-1lox/ CMV-Cre mice to quantify
SOCS-1 promoter activity, CD4CD8lo thymocytes werewith IL-7, then STAT5 phosphorylation was measured
(Figure 4A). IL-7-induced STAT5 phosphorylation in still found to express high levels of SOCS-1 (Figure 5A).
We therefore purified CD4CD8lo thymocytes and ex-SOCS-1Lck-lox DP thymocytes was greatly increased com-
pared to control thymocytes. Little STAT5 phosphoryla- amined the effect of IL-7 on CD4/CD8 expression (Fig-
SOCS-1 Regulates CD8 T Cell Differentiation
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Figure 4. SOCS-1 Deficiency Increases the Potential of PMA/Ionomycin Signaled DP Thymocytes to Differentiate into CD8SP Cells in Response
to IL-7
(A) Purified DP thymocytes were treated with 0 to 2.5 ng/ml IL-7 for 30 min; then STAT5 phosphorylation was analyzed by Western blotting.
One of three experiments is shown.
(B) IL-7R and c expression levels on DP and CD8SP thymocytes.
(C) Purified DP thymocytes were signaled with 0.5 M PMA  0.5 g/ml ionomycin. After 16 hr, fresh media were replaced with the addition
of 2.5 ng/ml IL-7. The cultures were then analyzed for CD4 and CD8 expression over 14 days. Viable cell counts, determined by trypan blue
exclusion, are shown adjacent to each dot plot. Shown is the data from days 1 to 4 of one experiment.
(D) The pooled data from four experiments showing the percentage (mean SD) of CD8SP cells generated from days 2 to 14.
(E) The pooled data from four experiments showing the ratio (mean SD) of CD8SP:CD4SP cells in the days 2 to 14 cultures. Statistical
significance: * p 	 0.05 and ** p 	 0.005 compared with genetic controls.
ures 5B and 5C). In the absence of IL-7, only CD4SP vitro appeared as CD3hiTCR
hiHSAlo (data not shown).
These results suggest that SOCS-1-deficient DP thymo-and DP cells were present in SOCS-1Lck-lox and control
cultures after 48 hr. In IL-7-treated control cultures, how- cytes recently selected in vivo are also hyperresponsive
to IL-7-induced CD8SP differentiation.ever, one-fifth of cells became CD8SP. Treatment with
a combination of IL-7, IL-2, and IL-15 increased the ratio
of CD8SP cells to one-third of the culture. One-third of SOCS-1-Deficient Thymocytes Are Normally Deleted
in Models of Negative SelectionSOCS-1Lck-lox cells treated with IL-7 alone appeared as
CD8SP, while IL-7/2/15 treatment resulted in two-thirds SOCS-1 could also potentially have a role in regulating
negative selection. This was addressed using the Staph-of cells differentiating into CD8SP. Treatment with either
IL-2 or IL-15 alone did not generate CD8SP cells in ylococcal enterotoxin B (SEB) model of negative selec-
tion in fetal thymic organ cultures (Aiba et al., 1993).control cultures but consistently generated a small per-
centage of CD8SP cells in SOCS-1Lck-lox cultures. Pheno- SOCS-1 is expressed in fetal thymic organ cultures (Fig-
ure 6A). SEB is a superantigen that engages TCR V
8,typically, both CD4SP and CD8SP cells generated in
Immunity
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Figure 5. SOCS-1-Deficient DP Thymocytes
Positively Selected In Vivo Are Hyperrespon-
sive to IL-7-Induced Differentiation into
CD8SP Cells
(A) Recently selected DP thymocytes were
identified as CD4CD8lo cells. SOCS-1 pro-
moter activity was analyzed by measuring
hCD4 expression on SOCS-1lox/ CMV-Cre
thymocytes.
(B) Purified CD4CD8lo thymocytes were cul-
tured with 5 U/ml IL-2, 2.5 ng/ml IL-7, 10 ng/
ml IL-15, or all three cytokines for 48 hr. The
cells were then analyzed for CD4 and CD8
expression. The viable cell counts, deter-
mined by trypan blue exclusion, are adjacent
to each dot plot. A representative experiment
is shown.
(C) The pooled data from three experiments
is shown in (C) as the ratio (mean SD) of
CD8SP:CD4SP cells generated. Statistical
significance: * p	 0.05 and ** p	 0.005 com-
pared with genetic controls.
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Figure 7. SOCS-1-Deficient Naive CD8 T Cells Upregulate CD44
Expression in Response to c Cytokines Alone
Purified mature CD8SP thymocytes were stimulated with 5 U/ml IL-
2, 2.5 ng/ml IL-7, or 10 mg/ml IL-15 in the presence or absence of
plate-bound anti-CD3 antibody. After 48 hr, the cells were analyzed
for CD44 expression. One of four experiments is shown.
tive selection was also examined. SOCS-1/ IFN/
mice, which do not develop the neonatal SOCS-1/
disease and thymic atrophy (Alexander et al., 1999), and
IFN/ mice as controls were injected with anti-CD3
antibody at several doses; then, the deletion of thymo-
cyte populations were analyzed. Similar reductions in
thymocytes populations were found in SOCS-1/
IFN/ and IFN/ mice (data not shown). These results
suggest that SOCS-1 is unlikely to have a role in regulat-
ing the negative selection of thymocytes.
Figure 6. V
8 Thymocyte Deletion in the SEB Model of Negative
Selection Is Not Affected by SOCS-1 Deficiency SOCS-1-Deficient Naive CD8 T Cells Are
(A) The thymic lobes from 26 embryos at E15 were cultured for 12 Hyperresponsive to c Cytokine-Induced
days and then pooled (3  106 cells) and analyzed for SOCS-1 CD44 Upregulation
protein expression. Thymocytes (2 107 ) from a 6-week-old mouse
In addition to regulating lineage commitment in the thy-were used a positive control for SOCS-1 expression.
mus, IL-7 is involved in the generation and maintenance(B) Thymic lobes from E15 SOCS-1/ or SOCS-1/,/ littermate
embryos were treated with either PBS (vehicle) or SEB. After 12 of the memory (CD44hi) CD8 T cell pool (Schluns et al.,
days, the specific deletion of TCR V
8 thymocytes was determined 2000). The CD44hi expression on peripheral CD8 T cells
by flow cytometry. The results are expressed as the percentage in SOCS-1Lck-lox mice could also be dependent on IL-7
(meanSD) of live thymocytes that are CD4SP or CD8SP, and V
8. hypersensitivity. To examine this, mature CD8SP thymo-
(C) As a control, the percentage of V
5 thymocytes which should
cytes were purified from SOCS-1Lck-lox mice and stimu-not be deleted was also determined.
lated with IL-7 in vitro (Figure 7). The thymus was used
as the source of naive CD8 T cells because very few
CD44lo cells were found in the periphery of SOCS-1Lck-loxresulting in specific deletion of V
8 thymocytes. Equiv-
alent deletion of V
8 thymocytes were found in mice. Treatment with IL-7 alone upregulated CD44 ex-
pression on one-fifth of SOCS-1Lck-lox cells, whereasSOCS-1/ and littermate control (SOCS-1/,/) fetal
thymic organ cultures (Figure 6A). There was no deletion CD44 expression was unchanged in control cells. Other
c cytokines, IL-2 and IL-15, also upregulated CD44of V
5 thymocytes in either SOCS-1/ or control cul-
tures (Figure 6B). expression on SOCS-1Lck-lox cells. In contrast, upregula-
tion of CD44 on control CD8SP thymocytes requiredThe anti-CD3 antibody administration model of nega-
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activation with anti-CD3 in combination with a c cyto- Jeffry et al., 1995). Therefore, the lower levels of SOCS-1
found in DN thymocytes are unlikely to have significantkine. Anti-CD3 treatment alone was sufficient to upregu-
late CD44 expression on SOCS-1Lck-lox cells, but this is inhibitory actions on IL-7 signaling. Moreover, there was
no evidence of abnormal DN population sizes inprobably dependent on the stimulation of endogenous
IL-2 production. These results suggest that hypersensi- SOCS-1Lck-lox mice. In contrast, SOCS-1 overexpression
early in thymocyte development inhibits IL-7 signalingtivity to c cytokines might be responsible for the abnor-
mal memory CD8T cell phenotype in SOCS-1Lck-lox mice. and impairs transition from the DNII to DNIII stage (Fuji-
moto et al., 2000).
Almost all peripheral CD8 T cells but not CD4 T cellsDiscussion
in SOCS-1Lck-lox mice appeared as CD44hi. This resembles
a memory rather than activated phenotype becauseSOCS-1 and T Cell Development
CD25 or CD69 were not upregulated concurrently. IL-7In this study, we have generated a combined SOCS-1
and IL-15 are both implicated in the generation andconditional deficient/SOCS-1 reporter mouse. The flexi-
maintenance of the memory CD8 T cell pool in mice.bility and sensitivity of the cell surface hCD4 reporter has
IL-15/ mice lack memory CD8 T cells (Kennedy et al.,allowed for more detailed analysis of SOCS-1 promoter
2000), but this can be overcome by IL-7 overexpressionactivity at the single-cell level than was previously possi-
(Kieper et al., 2002). Additionally, memory CD8 T cellsble. Using this reporter, promoter activity was evident
are unable to survive in IL-7/ hosts (Schluns et al.,throughout the T cell compartment and at particularly
2000). The high percentage of memory CD8 but nothigh levels at the DP thymocyte stage, which correlated
CD4 T cells in SOCS-1Lck-lox mice is reminiscent of thatwith SOCS-1 protein expression. This promoter activity
seen in mice that transgenically overexpress either IL-7in DP thymocytes is unlikely to be dependent on a solu-
or IL-15 (Fehniger et al., 2001; Kieper et al., 2002). There-ble factor because only low levels were seen in DN
fore, IL-7 and/or IL-15 hypersensitivity could also be thethymocytes despite all DN, ISP, and DP thymocytes
cause of the memory CD8 T cell phenotype in SOCS-being present in the thymic cortex. Signaling through
1Lck-lox mice. Indeed, we found that naive CD8 T cellsTCR is unlikely to cause the high promoter activity either
that lacked SOCS-1 could upregulate CD44 in responsebecause promoter activity increases from the ISP stage
IL-7 or IL-15 alone, whereas control cells required thebefore the upregulation of TCR components. In addition,
additional signal of anti-CD3 treatment. IL-2 also hadcombinations of cytokines (including IFN, IL-2, or IL-7)
the same effect. It has recently been shown that SOCS-and TCR activation are unable to achieve the same level
1/Rag1/ mice that are transgenic for the OT-1 TCRof expression in other thymocyte or T cell populations
also display CD44hi expression on peripheral CD8(M.M.W.C. and T.W.H.K., unpublished data). These con-
T cells (Cornish et al., 2003). Because the CD8 T cellsfirm a previous study which reported that SOCS-1 is
in these mice only recognize an exogenous antigen,still expressed in Jak3/ or Rag2/ thymocytes, which
ovalbumin, this suggests that the CD44 upregulationsuggests that neither c cytokine nor TCR signaling is
caused by SOCS-1 deficiency is not dependent on TCRrequired for this SOCS-1 expression (Marine et al., 1999).
signaling. Therefore, SOCS-1 is a critical regulator ofTherefore, SOCS-1hi expression at the DP stage is poten-
signaling by multiple c cytokines at different stages intially regulated developmentally. Moreover, thymocytes
CD8 T cell differentiation.have downregulated expression by the time they are
mature TCRhi CD4SP or CD8SP.
SOCS-1hi expression at the DP stage in thymocyte T Cells and the SOCS-1/ Disease
Disruption of the SOCS-1 gene in mice has clearly dem-development appears to have a role in regulating IL-7
signaling. SOCS-1Lck-lox mice display a large increase onstrated its importance for survival. However, the pri-
mary cause of the neonatal disease remains unclear.CD8SP thymocyte population and in the ratio of
CD8:CD4 T cells maturing from the thymus. A prefer- Hypersensitivity of tissues to IFN (Alexander et al.,
1999) and the abnormal activation of T cells and NKTential increase in the CD8 T cell population has pre-
viously been described in transgenic mice overexpress- cells, which in turn mediate the inflammatory disease
(Marine et al., 1999; Naka et al., 2001), are two proposeding IL-7 (Mertsching et al., 1995). Using in vitro systems
of thymocyte differentiation, positively selected thymo- mechanisms of the SOCS-1/ disease. While there is
evidence supporting both these hypotheses, the ques-cytes can be preferentially induced to differentiate into
CD8SP cells in the presence of IL-7 (Brugnera et al., tion of which (or both) mechanism has been difficult
to address. This is because of the complexity of the2000; Varas et al., 1997). One would expect that the loss
of a negative regulator of cytokine signaling, SOCS-1, SOCS-1/ disease and the likelihood that SOCS-1 defi-
ciency has multiple effects in vivo. By employing the Cre/could result in hyperresponsiveness to IL-7 during thy-
mocyte development. Indeed, we found that loss of LoxP system to delete SOCS-1 in only specific tissues,
some of these problems have been circumvented.SOCS-1 resulted in IL-7 responsiveness (STAT5 phos-
phorylation) in DP thymocytes, despite the expression SOCS-1 deficiency in the hematopoietic compartment
is thought to be sufficient to cause disease becauseof only low levels of IL-7R. Furthermore, SOCS-1-defi-
cient DP thymocytes positively selected in vitro or in transfer of SOCS-1/ bone marrow into irradiated
Jak3/ recipients results in premature lethality (Marinevivo were hyperresponsive to IL-7-induced differentia-
tion into CD8SP cells. et al., 1999). SOCS-1/ Rag2/ mice do not develop
the neonatal SOCS-1/ disease, suggesting that lym-IL-7 is also important at the earlier stages in thymocyte
development because development is blocked at the DN phocytes (specifically T cells) are responsible for medi-
ating the SOCS-1/ pathology. In this study, we havestages in IL-7/ mice (Moore et al., 1996; von Freeden-
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trates the structure of the SOCS-1 gene. The HindIII to EcoRI frag-shown that SOCS-1 deficiency in T/NKT cells alone is
ment, containing the SOCS-1 gene and 1.5 kb of 5 flanking region,insufficient to cause the SOCS-1/ disease and neona-
was subcloned into pBluescript. The SOCS-1 gene was flanked bytal lethality. SOCS-1Lck-lox mice do not develop any of the
LoxP sites by inserting the oligonucleotides 5-CGAATTCCATAACT
inflammatory pathologies evident in SOCS-1/ mice. TCGTATAGCATACATTATACGAAGTTATCGCATG-3 and 5-AATT
Apart from the CD44hi phenotype of CD8 T cells, little CCATAACTTCGTATAGCATACATTATACGAAGTTATCGGCGCGCC
AAGCTTG-3 into the SphI and EcoRI sites, respectively. An EcoRIevidence of abnormal T cell activation was found in
site was also inserted with the 5 LoxP site to allow for geneticSOCS-1Lck-lox mice. Therefore, SOCS-1 deficiency in
screening. A human CD4-SV40 polyA cassette (obtained from Prof.other hematopoietic compartments in addition to T/NKT
Jerry Adams, The Walter and Eliza Hall Institute) was ligated aftercells may be required for the lethality observed in
the 3 LoxP site, followed by a PGKhygro cassette (flanked by FRT
SOCS-1/ mice or in mice reconstituted with SOCS-1/ sites). Finally, the EcoRI to EcoRV fragment (3 flanking region) from
bone marrow. It is clear that SOCS-1 has important 95-11-10 was ligated after the FRT- PGKhygro-FRT cassette to gen-
erate the targeting vector. The vector was targeted into C57BL/6functions in other hematopoietic cell types. For exam-
embryonic stem cells. Two targeted clones were injected intople, SOCS-1 regulates the sensitivity of macrophages
BALB/c blastocysts to generate chimeric mice.to lipopolysaccharide (Kinjyo et al., 2002; Nakagawa et
al., 2002) and the sensitivity of NK cells to IL-12-induced
Other Mice and Reagentsactivation (Eyles et al., 2002). In addition, SOCS-1 defi-
SOCS-1/ mice (Starr et al., 1998), CMV-Cre transgenic miceciency also causes hypersensitivity to other cytokines
(Schwenk et al., 1995), and Lck-Cre transgenic mice (Orban et al.,
such as tumor necrosis factor (TNF) (Chong et al., 2002) 1992) have been previously described. All mice were backcrossed
and IL-4 (Naka et al., 2001). onto the C57BL/6 background for more than ten generations. The
Lck-Cre mouse was a kind gift from Dr. Theo Mantamadiotis, TheIt was also shown by Marine et al. (1999) that the bone
Peter MacCallum Cancer Institute.marrow of SOCS-1/ mice contained a large proportion
The cytokines used were recombinant human IL-2 (McKessonof activated T cells (12% of the total bone marrow). The
HBOC, Rockville, MD), murine IL-7 (provided by Dr. Stephen Nutt,transfer of activated T cells (as part of the bone marrow
The Walter and Eliza Hall Institute), recombinant human IL-15 (Pe-
transfer) into a lymphopenic environment would result protech, Rocky Hill, NJ), and recombinant murine IFN (Genentech,
in homeostatic proliferation and activation (Oehen and South San Francisco, CA).
Brduscha-Riem, 1999; Tanchot et al., 2001). This may
have contributed to the disease reported in bone mar- Genotyping of Mice
The SOCS-1 null, wild-type, and lox alleles were determined byrow transfers but would not have been a factor in the
Southern blotting EcoRI-digested genomic DNA with probe A (indi-Cre/LoxP approach used in this study.
cated in Figure 1A). Cre transgenic mice were genotyped by PCRInterestingly, in the reported transfer studies, recipient
using the primers 5-AAATTTGCCTGCATTACCGG-3 and 5-ACACmice did not die until 3 months after receiving SOCS-
CTGCGGTGCTAACCAG-3.
1/ bone marrow (Marine et al., 1999). This is in contrast Recombination of the SOCS-1lox allele was examined by Southern
to the rapid inflammatory disease that germ-line SOCS- blotting BamHI-digested genomic DNA with probe B (indicated in
Figure 1A). The 6.0 and 4.5 kb fragments correspond to the SOCS-1lox1/ mice develop. This may reflect the time required for
and recombined SOCS-1lox alleles, respectively.bone marrow reconstitution but also suggests that the
full-blown SOCS-1/ disease may require deficiency in
Histological Analysesnonhematopoietic tissues. SOCS-1 deficiency in target
For histological analyses, tissues were fixed in 10% neutral-bufferedtissues alone, such as in hepatocytes, is also insufficient
formalin and paraffin-embedded, and then sections were stainedto recapitulate the SOCS-1/ disease (M.M.W.C., un-
with hematoxylin and eosin. Tissues for immunohistochemistry were
published data). The full-blown SOCS-1/ disease could fixed in 4% paraformaldehyde in PBS for 2 hr at 4C prior to freezing
be caused by SOCS-1 deficiency in both T cells and in OCT mounting medium (Sakura Finetechnical, Tokyo, Japan).
Sections were stained with monoclonal antibodies (clone name intarget tissues. The fact that the T cells in SOCS-1Lck-lox
brackets) recognizing human CD4 (RPA-T4), murine CD4 (H129.19),mice do not display full activation and do not infiltrate
and murine CD8 (53-6.7) (BD Pharmingen, San Diego, CA).any organs suggests that additional signals are required
for T cell activation and infiltration into tissues. Perhaps
Flow CytometrySOCS-1 deficiency in target tissues causes hypersensi-
Monoclonal antibodies recognizing the following antigens (clonetivity to normal circulating levels of cytokines such as
name in brackets) were used for flow cytometric analyses: murine
IFN and TNF, which results in the induction of IFN/ CD3 (KT3), CD4 (H129.19), CD8 (53-6.7), CD25 (7D4), CD44 (IM7),
TNF-regulated chemokines and cytokines, such as IL-7 CD127/IL-7R (B12-1), CD132/c (4G3), TCR
 (H57-597), TCR V
5
(MR9-4), TCR V
8 (F23.1), NK1.1 (PK136), and human CD4 (RPA-and IL-15. Many of the tissues that are infiltrated in
T4). All antibodies were purchased from BD Pharmingen. AnalysesSOCS-1/ mice, such as the liver, heart, and pancreas,
were performed on a LSR or FACStar Plus (BD Immunocytometry).are sites of IL-7 and IL-15 production (Cardozo et al.,
Cell sorting was performed on a MoFlo (Cytomation, Fort Collins, CO).2001; Golden-Mason et al., 2001; Grabstein et al., 1994).
In addition, IL-7 and IL-15 are stimulators of IFN and
Immunoprecipitation and Western Blot AnalysesTNF production by T cells (Borger et al., 1996; McInnes
Thymocytes were prepared as single-cell suspensions. SOCS-1 pro-
et al., 1997). This positive interaction between IFN/TNF tein expression was measured by immunoprecipiation-Western
and IL-7/15 together with hypersensitivity to all these blotting as previously described (Chong et al., 2001).
STAT5 phosphorylation was analyzed by Western blotting. Proteincytokines could be required for the SOCS-1/ disease.
extracts was obtained by cell lysis as previously described (Chong
et al., 2001). The protein extract from 2.5  106 thymocytes wasExperimental Procedures
resolved on a 7.5% polyacrylamide gel and transferred to nitrocellu-
lose membrane. The monoclonal antibody ST5P-4A9 was used toGeneration of SOCS-1lox Mice
The genomic murine SOCS-1 clone 95-11-10 was obtained from Dr. detect phosphorylated STAT5a/b. Blots were stripped and reprobed
with the monoclonal antibodies ST5a-2H2 and ST5b-10G1 to detectTracy Willson, The Walter and Eliza Hall Institute. Figure 1A illus-
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total STAT5a and b. All anti-STAT5 antibodies were purchased from by overexpression of suppressor of cytokine signaling-1. Diabetes
50, 2744–2751.Zymed Laboratories (South San Francisco, CA).
Chong, M.M.W., Thomas, H.E., and Kay, T.W.H. (2002). Suppressor
Thymocyte Suspension and Fetal Thymic Organ Cultures of cytokine signaling-1 regulates the sensitivity of pancreatic 
 cells
Thymocyte populations from 6-week-old mice were purified by cell to tumor necrosis factor. J. Biol. Chem. 277, 27945–27952.
sorting. In vitro differentiation of CD4CD8 thymocytes was per-
Cornish, A.L., Davey, G.M., Metcalf, D., Purton, J.F., Corbin, J.E.,
formed according to the method of Brugnera et al. (2000). Over a 2
Greenhalgh, C.J., Darwiche, R., Wu, L., Nicola, N.A., Godfrey, D.I.,
week period, the cells were harvested, and cell viability was deter-
et al. (2003). Suppressor of cytokine signaling-1 has IFN--indepen-
mined by trypan blue exclusion and counting on a hemocytometer;
dent actions in T cell homeostasis. J. Immunol. 170, 878–886.
then analyzed by flow cytometry. Other thymocyte populations were
Eyles, J.L., Metcalf, D., Grusby, M.J., Hilton, D.J., and Starr, R. (2002).also cultured with various cytokines prior to analysis by flow cytome-
Negative regulation of interleukin-12 signaling by suppressor of cy-try. In some experiments, cells were also stimulated with plate-
tokine signaling-1. J. Biol. Chem. 277, 43735–43740.bound anti-CD3 (145-2C11, produced in-house).
Fehniger, T.A., Suzuki, K., Ponnappan, A., VanDeusen, J.B., Cooper,Fetal thymic organ cultures were performed on embryonic day
M.A., Florea, S.M., Freud, A.G., Robinson, M.L., Durbin, J., and Cali-15 thymic lobes as previously described (Godfrey et al., 1994). They
giuri, M.A. (2001). Fatal leukemia in interleukin 15 transgenic micewere cultured for 12 days with or without 10 g/ml SEB (Toxin
follows early expansions in natural killer and memory phenotypeTechnology, Sarasota, FL); then the thymocytes were analyzed by
CD8 T cells. J. Exp. Med. 193, 219–231.flow cytometry.
Fujimoto, M., Naka, T., Nakagawa, R., Kawazoe, Y., Morita, Y., Ta-
Statistical Analyses teishi, A., Okumura, K., Narazaki, M., and Kishimoto, T. (2000). Defec-
Statistical comparisons made using the Mann-Whitney test calculated tive thymocyte development and perturbed homeostasis of T cells in
with Prism version 2.0a (GraphPad Software Inc., San Diego, CA). STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1
transgenic mice. J. Immunol. 165, 1799–1806.
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